FDA Approved: OXCARBAZEPINE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for oxcarbazepine from Bionpharma Inc., granting additional authorization under ANDA 209652.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)